Research Article

Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves’ Ophthalmopathy through the Regulation of FoxO3a Signaling

Table 1

Characteristics of patients with Graves’ ophthalmopathy (GO) and non-GO control subjects included in this study.

GO patients ()Control subjects ()

Mean age (years)
Sex (male/female)2/42/4
Smoking ()21
Duration of GD (months)
Duration of GO (months)
Previous orbital irradiation0
Previous steroid pulse therapy0
Euthyroid66
TSH receptor antibodies60
Clinical activity score

GD = Graves’ disease; TSH = thyroid-stimulating hormone.